Clin Assoc Prof Helen Oh May Lin

Dr Helen Oh is a Senior Consultant with the Department of Infectious Diseases at Changi General Hospital (CGH). She received her medical degree from the National University of Singapore. She then went on to receive training in adult Infectious Disease from the University of British Columbia, Canada, as well as in molecular diagnostics from the University of Alabama, Birmingham, USA.

Dr Oh is a member of the Technical Advisory Group (TAG) on immunization and vaccine preventable diseases, Western Pacific Regional Office, World Health Organisation since 2011. Her research interests include dengue immunology, nosocomial infections, travel vaccines as well as environmental decontamination.

• MBBS (Singapore)
• M Med (Int Med)
• MRCP (UK)
• FRCP (Edin)
• FRCP (Glas)
• Specialist Accreditation, Infectious Diseases (Singapore)

• Clinical Associate Professor - NUS Yong Loo Lin School of Medicine, Infectious Diseases
• Clinician Physician Faculty Member
• Member - FAMS
• MFTM - RCPS

• 2012 - National Day Award, The Long Service Medal, Ministry of Health
• 2011 - Long Service Award, (Expert Committee for Immunisation), Ministry of Health
• 2003 - National Day Award
• 2003 - Courage Medal, Pingat Kepujian

• Prophylactic platelet transfusion plus supportive care versus supportive care alone in adults with dengue and thrombocytopenia: open, randomized, superiority trial. DC Lye, S Archuleta, SF Syed-Omar, JG Low, HM Oh, Y Wei, D Fisher, SSL Ponnampalavanar, L Wijaya, LK Lee, EE Ooi, A Kamarulzaman, LC Lum, PA Tanbyah, YS Leo. Lancer 2017;389:1611-1618.
• Risk factors for fatality among confirmed adult dengue inpatients in Singapore: A matched case-control study. YL Thein, YS Leo, DA Fisher, GG Low, HML Oh, VC Gan, JGX Wong, DC Lye. PLOS One 2013;8:e1060.
• Automated measures of hand hygiene compliance among healthcare workers using ultrasound: Validation and a Randomized controlled trial. DA Fisher, S Seetoh, HML Oh, S Viswanathan, YL Toh, CY Wong, SW Loh, SY Tan, S Schiefen, M Je, F Peh, FWL Loke, M Dempsey. Inf Control Hosp Epidemiol 2013; 34:919-928.
• Immunogenicity and safety of recombinant tetravalent dengue vaccine (CYD-TDV) in individuals aged 2-45 years phase II randomized controlled trail in Singapore. YS Leo, A Wilder-Smith, S Archuletta, LP Shek, CY Chong, MLH Oh et al. Human Vaccines and Immunotherapeutics 2012; 81:1259-7
• Clinico-genetic characterisation of an encephalitic Dengue virus 4 associated with multi-organ involvement. HC Hapuarachchi, HML Oh, TL Thein, KY Pok, YL Lai, IK Tan, KS Lee, YS Leo, LL Ng. J Clin Virology 2013; 57:91-94
• Confirmed adult dengue deaths in Singapore; 5 year multi-centre retrospective study. Leo YS, Thein TL, Fisher D, Low JG, Oh HM, Narayanan R et al. BMV Infect Dis 2011;11:123